Financial Management Professionals’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Financial Management Professionals’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47	Closed	-$5K	–	1168
2023 Q1	$5K	Buy	+47	New	+$5.2K	﹤0.01%	703
2018 Q4	–	Sell	-487	Closed	-$10K	–	337
2018 Q3	$10K	Buy	+487	New	+$9.26K	﹤0.01%	180

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Financial Management Professionals's HZNP Position: Q2 2023 in Review

Financial Management Professionals sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 47 shares — an estimated $5K sold.

Financial Management Professionals first reported a position in HZNP in Q3 2018 and held it in 2 quarters. The position peaked at $10K in Q3 2018. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Financial Management Professionals reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Financial Management Professionals sold 47 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $5K.
Financial Management Professionals first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 2 quarters.
Financial Management Professionals's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10K in Q3 2018.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Financial Management Professionals's 13F filing for Q2 2023, filed 10 Jul 2023.